Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Caplan

Showing results (401-410 of 404) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 404 results.
The Journal of Experimental Medicine|July 21, 2004
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potentialGesine Kögler, Sandra Sensken, Judith A Airey, et al.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming|June 24, 2021
Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)G Lanzoni, E Linetsky, D Correa, et al.
Stem Cells Translational Medicine|May 31, 2022
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisWenchun Qu, Zhen Wang, Erica Engelberg-Cook, et al.
Stem Cells Translational Medicine|January 5, 2021
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialGiacomo Lanzoni, Elina Linetsky, Diego Correa, et al.
Pageof 41

Showing results (401-410 of 404) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 404 results.
The Journal of Experimental Medicine|July 21, 2004
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potentialGesine Kögler, Sandra Sensken, Judith A Airey, et al.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming|June 24, 2021
Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)G Lanzoni, E Linetsky, D Correa, et al.
Stem Cells Translational Medicine|May 31, 2022
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisWenchun Qu, Zhen Wang, Erica Engelberg-Cook, et al.
Stem Cells Translational Medicine|January 5, 2021
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialGiacomo Lanzoni, Elina Linetsky, Diego Correa, et al.
Pageof 41